Rokit Healthcare Accelerates China Expansion, First Exports of Skin Regeneration Devices in Early December, Treatment Launch Next Year
Predicted impact: Low
China export and expansion news; FDA warning already noted, no new material figures.
Rokit Healthcare로킷헬스케어
376900 · KOSDAQ · ₩376900 · 로킷헬스케어
₩19,450▲ ₩3,480 (21.79%)End-of-day · Oct 29, 2026 · End-of-day prices.
Rokit Healthcare to make first China export in December, plans regenerative diabetic foot treatment procedure in January next year
Predicted impact: Low
Small China export start; overlapping with earlier Rokit news, modest revenue size.
Rokit Healthcare adds cartilage regeneration indication, full-scale push into Europe
Predicted impact: Medium
New cartilage indication and Europe push for a small company, but no size given; US uncertainty persists.
Rokit Healthcare to study kidney patch with Harvard; confirms function preservation and pursues clinical trials
Predicted impact: Low
Research collaboration with Harvard; early-stage, no revenue impact disclosed.
Rokit Healthcare Blames Distributor for FDA Warning; Uncertainty Rises for US Business Without Treatment Device Approval↑
Predicted impact: Medium
FDA warning and US distributor contract termination create uncertainty for US business; size not disclosed.
Rokit Healthcare presents joint Harvard research results at American Society of Nephrology meeting
Predicted impact: Low
Research presentation on AI prediction; same product news already reported; contract termination was a separate prior item.
Rokit Healthcare Pursues Termination of Contract with US Distributor…Says Unrelated to Product Defects
High impactPredicted impact: High
Termination of US distribution deal for a firm with small revenue; size of contract unknown.
Rokit Healthcare predicts risk for 35 diseases with AI, targets health management market
Predicted impact: Low· Actual: −22.6% vs sector, volume 2.9× normal (5 trading days)
AI disease-prediction product launch; no contract size or financial figures given.
ROKIT Healthcare launches AI engine predicting 35 diseases, targeting global market
Predicted impact: Low· Actual: −17.2% vs sector, volume 2.1× normal (5 trading days)
ROKIT Healthcare pushes overseas with AI prediction
Predicted impact: Low· Actual: −17.2% vs sector, volume 2.1× normal (5 trading days)
Olix Plunges 14% and Lockit Healthcare Hits 52-Week Low as Clinical Trial Application Rejected [Bio Market Briefing]
Predicted impact: Medium· Actual: −10.0% vs sector, volume 0.6× normal (5 trading days)
Clinical trial application rejection at a different company; Rokit impact unclear, only a 52-week low noted.
Also known as: Rokit Healthcare / 로킷헬스케어 / 376900 / KRX:376900
Source: KRX statistical information